Advertisement
Screener

NATURE’S SUNSHINE PRODUCTS, INC. (NATR) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

NATURES SUNSHINE PRODUCTS INC Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • NATURES SUNSHINE PRODUCTS INC return tang equity for the quarter ending 2026-06-30 was 11.08%, a 26.28% increase year-over-year.
  • NATURES SUNSHINE PRODUCTS INC return tang equity for the quarter ending 2026-03-31 was 12.43%, a 101.32% increase year-over-year.
  • NATURES SUNSHINE PRODUCTS INC return tang equity for the quarter ending 2025-12-31 was 12.70%, a 158.23% increase year-over-year.
  • NATURES SUNSHINE PRODUCTS INC return tang equity for the quarter ending 2025-09-30 was 9.15%, a 17.45% decline year-over-year.
  • NATURES SUNSHINE PRODUCTS INC return tang equity for fiscal 2025 was 12.70%, a 158.23% increase from fiscal 2024.
  • NATURES SUNSHINE PRODUCTS INC return tang equity for fiscal 2024 was 4.92%, a 52.36% decline from fiscal 2023.
  • NATURES SUNSHINE PRODUCTS INC return tang equity for fiscal 2023 was 10.33%, a 2650.17% increase from fiscal 2022.
  • NATURES SUNSHINE PRODUCTS INC return tang equity for fiscal 2022 was 0.38%, a 98.00% decline from fiscal 2021.
Available history
2012-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-3011.08%$18.7M$168.75M
2026-03-3112.43%$20.69M$166.35M
2025-12-3112.70%$20.45M$160.99M
2025-09-309.15%$15.21M$166.14M
2025-06-308.78%$14.32M$163.12M
2025-03-316.18%$10.29M$166.53M
2024-12-314.92%$7.89M$160.42M
2024-09-3011.09%$17.97M$162.05M
2024-06-3010.57%$16.46M$155.83M
2024-03-3111.09%$17.65M$159.14M
2023-12-3110.33%$16.42M$158.97M
2023-09-306.05%$9.16M$151.44M
2023-06-304.18%$6.21M$148.83M
2023-03-313.07%$4.49M$146.15M
2022-12-310.38%$550,000.00$146.48M
2022-09-308.69%$12.27M$141.19M
2022-06-3012.18%$17.53M$143.91M
2022-03-3115.66%$23.37M$149.21M
2021-12-3118.78%$30.21M$160.84M
2021-09-3015.68%$23.05M$147.06M
2021-06-3016.89%$24.77M$146.59M
2021-03-3117.10%$24.1M$140.93M
2020-12-3114.65%$22.96M$156.67M
2020-09-3011.87%$17.53M$147.67M
2020-06-308.44%$11.71M$138.67M
2020-03-316.22%$8.21M$132M
2019-12-315.38%$6.93M$128.87M
2019-09-302.30%$2.9M$126.15M
2019-06-302.32%$2.89M$124.12M
2019-03-310.16%$194,000.00$121.4M
2018-12-31-1.00%-$1.2M$119.95M
2018-09-30-13.03%-$16M$122.78M
2018-06-30-12.39%-$14.99M$120.95M
2018-03-31-12.76%-$15.35M$120.3M
2017-12-31-11.61%-$13.82M$119.02M
2017-09-30-2.68%-$3.63M$135.34M
2017-06-30-1.53%-$2.04M$132.71M
2017-03-310.56%$749,000.00$132.58M
2016-12-310.51%$675,000.00$131.42M
2016-09-308.03%$11.43M$142.41M
2016-06-307.14%$9.9M$138.62M
2016-03-317.25%$9.93M$136.89M
2015-12-3110.02%$13.66M$136.27M
2015-09-304.63%$6.23M$134.55M
2015-06-303.58%$4.81M$134.21M
2015-03-314.26%$5.65M$132.78M
2014-12-317.60%$9.8M$128.96M
2014-09-3011.52%$15.73M$136.6M
2014-06-3016.58%$19.59M$118.2M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-3112.70%$20.45M$160.99M
2024-12-314.92%$7.89M$160.42M
2023-12-3110.33%$16.42M$158.97M
2022-12-310.38%$550,000.00$146.48M
2021-12-3118.78%$30.21M$160.84M
2020-12-3114.65%$22.96M$156.67M
2019-12-315.38%$6.93M$128.87M
2018-12-31-1.00%-$1.2M$119.95M
2017-12-31-11.61%-$13.82M$119.02M
2016-12-310.51%$675,000.00$131.42M
2015-12-3110.02%$13.66M$136.27M
2014-12-317.60%$9.8M$128.96M
2013-12-3116.73%$17.61M$105.26M
2012-12-3121.95%$25.38M$115.64M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01